Log In
BCIQ
Print this Print this
 

Salvecin (AR-301) (formerly KBSA301)

  Manage Alerts
Collapse Summary General Information
Company Aridis Pharmaceuticals Inc.
DescriptionHuman IgG1 mAb against S. aureus alpha-hemolysin (aHL) generated using MabIgX technology
Molecular Target S. aureus alpha-hemolysin (aHL)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/27/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today